Edition:
United Kingdom

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

0.99USD
17 May 2018
Change (% chg)

$0.04 (+4.14%)
Prev Close
$0.95
Open
$0.97
Day's High
$0.99
Day's Low
$0.96
Volume
7,152
Avg. Vol
100,806
52-wk High
$2.65
52-wk Low
$0.69

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 0.00 -0.250
Sep 0.00 -0.531
Jun 0.00 -0.278
FY 2017 Mar '17 0.00 -0.325
Dec 1.25 -0.343
Sep 0.00 -0.416
Jun 0.00 -0.514
FY 2016 Mar '16 0.00 -4.445
Dec 0.00 -1.952
Sep 0.00 -5.263
Jun 0.00 -19.233
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-18 1 0.00 0.00 0.00 0.00
Year Ending Mar-19 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.55 -0.55 -0.55 -0.39
Year Ending Mar-18 1 -2.08 -2.08 -2.08 -1.72
Year Ending Mar-19 1 -1.89 -1.89 -1.89 -0.90
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.95 32.75
P/E High - Last 5 Yrs. -- 40.70 45.73
P/E Low - Last 5 Yrs. -- 23.63 24.23
Beta -0.57 0.89 0.88
Price to Sales (TTM) 13.68 3.94 5.71
Price to Book (MRQ) -- 4.81 5.37
Price to Tangible Book (MRQ) -- 5.61 6.94
Price to Cash Flow (TTM) -- 22.91 23.33
% Owned Institutions 18.15 1.21 2.16

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.51
Dividend 5 Year Growth Rate -- 4.47 5.32
Payout Ratio(TTM) -- 45.35 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.69 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 4.83 5.69
Sales - 5 Yr. Growth Rate -1.41 10.08 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 45.84 16.38 19.38
EPS (TTM) vs TTM 1 Yr. Ago 88.82 -- --
EPS - 5 Yr. Growth Rate -- 9.88 10.77
Capital Spending - 5 Yr. Growth Rate 49.14 15.52 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.12 2.19
Current Ratio (MRQ) 2.12 2.90 2.98
LT Debt to Equity (MRQ) -- 9.88 12.17
Total Debt to Equity (MRQ) -- 13.86 16.44
Interest Coverage (TTM) -5,804.00 35.89 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.81 54.45
Gross Margin - 5 Yr. Avg. -- 52.15 52.21
EBITD Margin (TTM) -838.44 -- --
EBITD - 5 Yr. Avg -3,202.01 18.57 10.96
Operating Margin (TTM) -843.66 14.36 4.73
Operating Margin - 5 Yr. Avg. -5,471.17 14.52 6.40
Pre-Tax Margin (TTM) -844.10 14.82 5.57
Pre-Tax Margin - 5 Yr. Avg. -6,012.32 14.91 6.82
Net Profit Margin (TTM) -844.30 11.08 1.87
Net Profit Margin - 5 Yr. Avg. -6,013.25 11.20 3.09
Effective Tax Rate (TTM) -- 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.42 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 938,098,556 847,034,055
Net Income/Employee (TTM) -- 110,370,574 99,640,144
Receivable Turnover (TTM) -- 5.63 5.78
Inventory Turnover (TTM) -- 2.59 3.35
Asset Turnover (TTM) 0.22 0.95 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -188.55 11.40 10.95
Return on Assets - 5 Yr. Avg. -1,968.05 12.91 12.32
Return on Investment (TTM) -245.77 14.84 14.38
Return on Investment - 5 Yr. Avg. -- 16.88 16.11
Return on Equity (TTM) -415.24 16.34 16.07
Return on Equity - 5 Yr. Avg. -- 17.98 17.39
  1 Year 3 Year 5 Year
Sales % -- -- -1.41
EPS (TTM) % 94.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for VistaGen Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.56%
# of Holders: 20
Total Shares Held: 3,105,475
3 Mo. Net Change: -2,548,905
# New Positions: 8
# Closed Positions: 6
# Increased Positions: 10
# Reduced Positions: 8
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.